Dry Mouth and Oral Deposition Complicate Saliva THC as a Blood Surrogate

Saliva THC cannot be treated as a fixed conversion of blood THC. A review of oral-fluid and blood drug measurements describes both biological transfer and collection problems, including dry mouth and material deposited directly in the mouth after cannabis use.

Oral fluid has more than one source of variation

Busardo and colleagues reviewed relationships among psychoactive drugs, blood, oral fluid and driving-related impairment. Their discussion explains that drug transfer into oral fluid depends on factors such as pH, protein binding, lipid properties and salivary flow.

For cannabis, oral deposition after smoked or oral exposure adds another issue. A measured concentration can reflect what remains in the oral cavity as well as processes related to circulating drug. A simple blood-to-saliva ratio can conceal that difference.

Dry mouth affects the specimen being collected

Reduced salivary flow can make obtaining an adequate specimen difficult. Collection volume and the circumstances of collection therefore belong alongside the analytical result. A concentration does not describe those conditions on its own.

This does not make oral-fluid testing useless. It defines the question it can address and the limitations of using it as a quantitative blood surrogate. Collection performance and assay performance also deserve separate consideration.

Avoid a second conversion into impairment

Even a close blood–oral-fluid relationship would not automatically establish a brain concentration or functional effect. Exposure detection, estimation of another specimen’s concentration and impairment assessment are distinct steps.

The supplied source is a review covering multiple drugs, rather than one new controlled cannabis trial. Its practical contribution is identifying variables that must be considered, not providing a universal cannabis conversion factor or an individual driving clearance.

Related: How the reference specimen changes a cannabis accuracy claim.

Research cited

Busardo FP; Pichini S; Pellegrini M; et al.; Current Neuropharmacology; 2018. Correlation between Blood and Oral Fluid Psychoactive Drug Concentrations and Cognitive Impairment in Driving under the Influence of Drugs.